Heim033780 • KRX
add
KT&G Corp
Við síðustu lokun
107.200,00 ₩
Dagbil
106.300,00 ₩ - 110.300,00 ₩
Árabil
83.500,00 ₩ - 113.500,00 ₩
Markaðsvirði
14,19 bn KRW
Meðalmagn
398,54 þ.
V/H-hlutf.
12,20
A/V-hlutfall
4,78%
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (KRW) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 1,42 bn | 6,57% |
Rekstrarkostnaður | 388,32 ma. | -3,18% |
Nettótekjur | 312,84 ma. | 55,80% |
Hagnaðarhlutfall | 21,97 | 46,17% |
Hagnaður á hvern hlut | 2,73 þ. | 57,13% |
EBITDA | 383,57 ma. | 25,52% |
Virkt skatthlutfall | 27,29% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (KRW) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,89 bn | 41,29% |
Heildareignir | 13,55 bn | 11,66% |
Heildarskuldir | 4,06 bn | 42,81% |
Eigið fé alls | 9,49 bn | — |
Útistandandi hlutabréf | 112,82 m. | — |
Eiginfjárgengi | 1,29 | — |
Arðsemi eigna | 6,02% | — |
Ávöxtun eigin fjár | 7,96% | — |
Peningaflæði
Breyting á handbæru fé
| (KRW) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 312,84 ma. | 55,80% |
Handbært fé frá rekstri | 206,50 ma. | -26,81% |
Reiðufé frá fjárfestingum | -84,69 ma. | 44,05% |
Reiðufé frá fjármögnun | -196,61 ma. | 65,68% |
Breyting á handbæru fé | -20,80 ma. | 95,32% |
Frjálst peningaflæði | -371,49 ma. | 19,81% |
Um
KT&G Corporation, originally Korea Tobacco & Ginseng, is the leading tobacco company in South Korea with annual sales over US$4 billion. KT&G was originally a government-owned monopoly but was privatized and today is publicly traded, competing for market share with other international tobacco firms such as Philip Morris International, British American Tobacco, and Japan Tobacco. KT&G's sales volume share was 62% of the Korean market in 2009.
KT&G also owns significant subsidiaries such as Korea Ginseng Corporation, Yungjin Pharm, and several bio ventures. Its headquarters are in Daejeon. Wikipedia
Framkvæmdastjóri
Stofnsett
apr. 1989
Höfuðstöðvar
Vefsvæði
Starfsfólk
4.250
